Over the past nine years, patients with spinal muscular atrophy have seen the number of FDA-approved treatment options for ...
Big drug maker Gilead expects to take a billion-dollar hit this year via drug-pricing provisions in the Inflation Reduction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback